Ludwig von Sallmann Clinician-Scientist Award
This award recognizes Ludwig von Sallmann, MD, a distinguished international ophthalmologist and ophthalmic investigator whose contributions greatly increased the basic and clinical understanding of vision and ophthalmology. Dr. von Sallmann served as chief of the Intramural Program of the National Eye Institute and was an ARVO Proctor Medal recipient in 1951. He also served on the staffs of Vienna, Beijing and Columbia Universities. First presented in 2011, the Ludwig von Sallmann Clinician-Scientist Award is supported by an anonymous donor through the ARVO Foundation.
Awardees will receive a $1,250 honorarium, an inscribed award and invitations to several special events at the ARVO Annual Meeting.
Eligibility
Eligible candidates are invited speakers to the ARVO Annual Meeting who hold an MD or MD/PhD (or equivalent) and who are age 45 or younger at the time of presentation. Award recipients will present a lecture at a scientific session, symposium or minisymposium at the ARVO Annual Meeting.
Application process
There is no application process for this award.
Review and selection process
Session organizers from the Annual Meeting Program Committee (AMPC) identify potential recipients who are young clinician-scientists. A selection committee evaluates and selects the recipient.
Timeline
Recipients notified in December.
Robert P. Finger, MD, MIH, PhD
Dr. Finger, the 2022 Ludwig von Sallmann Clinician-Scientist Award recipient, is an invited speaker for the LV cross-sectional group session, "Spotlight on macular disease: Impact on everyday function and wellbeing." Robert is a clinician-scientist specialized in retinal diseases and uveitis. His research focus is two-fold: Epidemiology and health services research as well as clinical research. The former includes the running of population-based, clinical and registry cohorts as well as the use of secondary data (such as health claim data), the latter both methods development related to clinical trial endpoints and outcomes research as well as the actual implementation of clinical trials. Robert is currently the deputy director of the Dpt. of Ophthalmology, University of Bonn, president of the European Eye Epidemiology Consortium, the principal investigator of the German national uveitis registry, the co-lead of the EU-IMI2 MACUSTAR consortium (www.macustar.eu) and the principal investigator of the ophthalmic part of the population based Rhineland Study.